Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of DepoCyte for CNS relapse in adult ALL or high‑grade lymphoma
2005-000173-21Phase 2Completed
- Sponsor
- Dieter Hoelzer, MD,PhD
- Start
- Oct 2005
- Modality
- Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of liposomal cytarabine in acute lymphoblastic leukemia (ALL), non-Hodgkin lymphoma (NHL) and central nervous system involvement by hematologic malignancy, sponsored by Dieter Hoelzer, MD,PhD. Primary endpoint: Response rate after one application of DepoCyte. Started Oct 2005; status: completed.
02
Drugs
liposomal cytarabine
03
Conditions
acute lymphoblastic leukemia (ALL)non-Hodgkin lymphoma (NHL)central nervous system involvement by hematologic malignancy
Beyond the preview
Go deeper on 2005-000173-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000173-21.